Carlos V. Paya is a businessperson who has been at the head of 6 different companies. Currently, Dr. Paya occupies the position of Chairman of Standard BioTools, Inc., Chairman for Vaxcyte, Inc., Executive Chairman at Highlight Therapeutics SL, Venture Partner at Ysios Capital Partners SGEIC SA and Venture Partner at Abingworth Management, Inc.

He is also on the board of Mallinckrodt Pharmaceuticals Ltd.

Dr. Paya previously held the position of Vice President for Eli Lilly & Co. and Vice President for Lilly Research Laboratories (a subsidiary of Eli Lilly & Co.), President, Chief Executive Officer & Director at Immune Design Corp., President of Elan Corp. Plc, President of Elan Pharmaceuticals, LLC and Professor-Medicine & Immunology at The Mayo Clinic (Old).

Dr. Paya received a doctorate from Universidad Complutense de Madrid.